Genetic Testing in African Americans

Running, not enrolling · Not applicable

Conditions studied: Ovarian Cancer, Endometrial Cancer, Peritoneal Cancer

In brief

This is a pilot/feasibility study to conduct genetic testing using tumor/blood samples of African American and Caucasian patients with ovarian and endometrial cancer following surgery at AU Health Medical Center. The aim of the pilot/feasibility study is to sequence a panel of cancer genes on paired tumor/blood (germline) samples of patients with ovarian and endometrial tumors at a two-week time point following surgery at AU Medical Center. While paired testing of tumor and blood (germline) provides direct clinical value to patients, investigators propose to study whether investigators can define and overcome such minority barriers among the Georgia Cancer Center (GCC)/AU Health Medical Center (AUMC) patient population.

Key facts

Study ID

NCT05591131

Run by

Augusta University

People needed

21

Starts

2023-04-20

Expected to finish

2027-11-01

Last updated by the study team

2025-02-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years of age.
• New diagnosis of ovarian, endometrial, fallopian, or primary peritoneal carcinoma.
• Diagnostic procedure performed at AU Health Medical Center.
• Adequate tissue is available for the tumor testing component (e.g., cytology and FNA samples are typically not adequate, whereas core biopsies and open biopsies usually are adequate.
• Consent at first post-biopsy outpatient clinic visit (typically about 2 weeks).
• Ability to provide informed consent in English.

You may not qualify if…

• There are no exclusion criteria

Where it is running

• Georgia Cancer Center at Augusta University — Augusta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.